Europe Therapeutic Nuclear Medicines Market Report 2017
- QYR1144982
- 101 Pages
- April 2017
- Medical Devices
Sales, means the sales volume of Therapeutic Nuclear Medicines
Revenue, means the sales value of Therapeutic Nuclear Medicines
This report studies sales (consumption) of Therapeutic Nuclear Medicines in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Cardinal Health Inc.
Mallinckrodt plc.
GE Healthcare
Lantheus Medical Imaging Inc.
Bayer AG
Bracco Imaging S.p.A
Eczacibasi-Monrol Nuclear Products
Nordion, Inc.
Advanced Accelerator Applications S.A.
IBA Molecular Imaging
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption) , revenue, market share and growth rate of Therapeutic Nuclear Medicines in these countries, from 2011 to 2021 (forecast) , like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Beta Emitters
Alpha Emitters
Brachytherapy Products
Split by application, this report focuses on sales, market share and growth rate of Therapeutic Nuclear Medicines in each application, can be divided into
Hospitals
Ambulatory Surgical Centers
Radiology Clinics
Europe Therapeutic Nuclear Medicines Market Report 2017
1 Therapeutic Nuclear Medicines Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters
1.2.2 Alpha Emitters
1.2.3 Brachytherapy Products
1.3 Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Radiology Clinics
1.4 Therapeutic Nuclear Medicines Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
2 Europe Therapeutic Nuclear Medicines by Manufacturers, Type and Application
2.1 Europe Therapeutic Nuclear Medicines Market Competition by Manufacturers
2.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Therapeutic Nuclear Medicines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Therapeutic Nuclear Medicines (Volume and Value) by Type
2.2.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
2.2.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
2.3 Europe Therapeutic Nuclear Medicines (Volume and Value) by Countries
2.3.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Countries (2012-2017)
2.4 Europe Therapeutic Nuclear Medicines (Volume) by Application
3 Germany Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
3.1 Germany Therapeutic Nuclear Medicines Sales and Value (2012-2017)
3.1.1 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.1.2 Germany Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
3.1.3 Germany Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
3.2 Germany Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
3.3 Germany Therapeutic Nuclear Medicines Sales and Market Share by Type
3.4 Germany Therapeutic Nuclear Medicines Sales and Market Share by Application
4 France Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
4.1 France Therapeutic Nuclear Medicines Sales and Value (2012-2017)
4.1.1 France Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.1.2 France Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
4.1.4 France Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
4.2 France Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
4.3 France Therapeutic Nuclear Medicines Sales and Market Share by Type
4.4 France Therapeutic Nuclear Medicines Sales and Market Share by Application
5 UK Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
5.1 UK Therapeutic Nuclear Medicines Sales and Value (2012-2017)
5.1.1 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.1.2 UK Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
5.1.5 UK Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
5.2 UK Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
5.3 UK Therapeutic Nuclear Medicines Sales and Market Share by Type
5.4 UK Therapeutic Nuclear Medicines Sales and Market Share by Application
6 Russia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
6.1 Russia Therapeutic Nuclear Medicines Sales and Value (2012-2017)
6.1.1 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
6.1.2 Russia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
6.1.6 Russia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
6.2 Russia Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
6.3 Russia Therapeutic Nuclear Medicines Sales and Market Share by Type
6.4 Russia Therapeutic Nuclear Medicines Sales and Market Share by Application
7 Italy Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
7.1 Italy Therapeutic Nuclear Medicines Sales and Value (2012-2017)
7.1.1 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
7.1.2 Italy Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
7.1.7 Italy Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
7.2 Italy Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
7.3 Italy Therapeutic Nuclear Medicines Sales and Market Share by Type
7.4 Italy Therapeutic Nuclear Medicines Sales and Market Share by Application
8 Spain Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
8.1 Spain Therapeutic Nuclear Medicines Sales and Value (2012-2017)
8.1.1 Spain Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
8.1.2 Spain Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
8.1.8 Spain Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
8.2 Spain Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
8.3 Spain Therapeutic Nuclear Medicines Sales and Market Share by Type
8.4 Spain Therapeutic Nuclear Medicines Sales and Market Share by Application
9 Benelux Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
9.1 Benelux Therapeutic Nuclear Medicines Sales and Value (2012-2017)
9.1.1 Benelux Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
9.1.2 Benelux Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
9.2 Benelux Therapeutic Nuclear Medicines Sales and Market Share by Manufacturers
9.3 Benelux Therapeutic Nuclear Medicines Sales and Market Share by Type
9.4 Benelux Therapeutic Nuclear Medicines Sales and Market Share by Application
10 Europe Therapeutic Nuclear Medicines Manufacturers Analysis
10.1 Cardinal Health Inc.
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Cardinal Health Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Mallinckrodt plc.
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Mallinckrodt plc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GE Healthcare
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Lantheus Medical Imaging Inc.
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Bayer AG
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Bracco Imaging S.p.A
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Bracco Imaging S.p.A Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Eczacibasi-Monrol Nuclear Products
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Nordion, Inc.
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Nordion, Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Advanced Accelerator Applications S.A.
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 IBA Molecular Imaging
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
11 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
11.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Therapeutic Nuclear Medicines Market Forecast (2017-2022)
14.1 Germany Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.2 France Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.3 UK Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.4 Russia Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.5 Italy Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.6 Spain Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.7 Benelux Therapeutic Nuclear Medicines Sales Forecast (2017-2022)
14.8 Europe Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
14.9 Europe Therapeutic Nuclear Medicines Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Therapeutic Nuclear Medicines
Table Classification of Therapeutic Nuclear Medicines
Figure Europe Sales Market Share of Therapeutic Nuclear Medicines by Type in 2015
Figure Beta Emitters Picture
Figure Alpha Emitters Picture
Figure Brachytherapy Products Picture
Table Application of Therapeutic Nuclear Medicines
Figure Europe Sales Market Share of Therapeutic Nuclear Medicines by Application in 2015
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Radiology Clinics Examples
Figure Germany Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure France Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure UK Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure Russia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure Italy Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure Spain Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure Benelux Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)
Table Europe Therapeutic Nuclear Medicines Sales of Key Manufacturers (2015 and 2016)
Table Europe Therapeutic Nuclear Medicines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Therapeutic Nuclear Medicines Sales Share by Manufacturers
Figure 2016 Therapeutic Nuclear Medicines Sales Share by Manufacturers
Table Europe Therapeutic Nuclear Medicines Revenue by Manufacturers (2015 and 2016)
Table Europe Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Therapeutic Nuclear Medicines Revenue Share by Manufacturers
Table 2016 Europe Therapeutic Nuclear Medicines Revenue Share by Manufacturers
Table Europe Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales and Market Share by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue and Market Share by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales and Market Share by Application (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Share by Application (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2012-2017)
Figure Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure Germany Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure Germany Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table Germany Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table Germany Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table Germany Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table Germany Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table Germany Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table Germany Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure France Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure France Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure France Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table France Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table France Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table France Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table France Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table France Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table France Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure UK Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure UK Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure UK Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table UK Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table UK Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table UK Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table UK Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table UK Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table UK Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure Russia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure Russia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table Russia Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table Russia Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table Russia Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table Russia Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table Russia Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table Russia Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure Italy Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure Italy Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table Italy Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table Italy Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table Italy Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table Italy Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table Italy Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table Italy Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure Spain Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure Spain Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure Spain Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table Spain Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table Spain Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table Spain Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table Spain Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table Spain Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table Spain Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Figure Benelux Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
Figure Benelux Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Figure Benelux Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
Table Benelux Therapeutic Nuclear Medicines Sales by Manufacturers (2015 and 2016)
Table Benelux Therapeutic Nuclear Medicines Market Share by Manufacturers (2015 and 2016)
Table Benelux Therapeutic Nuclear Medicines Sales by Type (2015 and 2016)
Table Benelux Therapeutic Nuclear Medicines Market Share by Type (2015 and 2016)
Table Benelux Therapeutic Nuclear Medicines Sales by Application (2015 and 2016)
Table Benelux Therapeutic Nuclear Medicines Market Share by Application (2015 and 2016)
Table Therapeutic Nuclear Medicines Basic Information List
Table Cardinal Health Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cardinal Health Inc. Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Mallinckrodt plc. Basic Information List
Table Mallinckrodt plc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mallinckrodt plc. Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table GE Healthcare Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Lantheus Medical Imaging Inc. Basic Information List
Table Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Bracco Imaging S.p.A Basic Information List
Table Bracco Imaging S.p.A Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bracco Imaging S.p.A Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Nordion, Inc. Basic Information List
Table Nordion, Inc. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Nordion, Inc. Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Advanced Accelerator Applications S.A. Basic Information List
Table Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table IBA Molecular Imaging Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2015
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure Germany Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure Germany Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure France Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure France Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure UK Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure UK Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure Russia Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure Italy Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure Spain Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales Forecast by Application (2017-2022)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
